Brief: Gamida Cell Initiates Rolling Submission Of Biologics License Application For Omidubicel
09/02/2022 12:14
Feb 9 (Reuters) - Gamida Cell Ltd GMDA.O :
* GAMIDA CELL INITIATES ROLLING SUBMISSION OF BIOLOGICS
LICENSE
APPLICATION FOR OMIDUBICEL
* GAMIDA CELL LTD - ON TRACK TO COMPLETE BLA SUBMISSION IN
FIRST
HALF OF 2022
Source text for Eikon: ID:nBw5Dg0qna
Further company coverage: GMDA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gamida Cell
See all newsBrief: Gamida Cell Appoints Joe Wiley As CEO
Brief: Gamida Cell Says District Court Of Beersheba, Israel Entered Judgment In Restructuring Proceeding
Israeli ADRs up on hopes of de-escalation in Israel-Iran tensions
Brief: Aquestive Therapeutics Strengthens Board Of Directors With Experienced Biotech Executive
Brief: Gamida Cell Ltd Says Received Notice From Nasdaq Notifying Co That It Determined Co’S Ordinary Shares Will Be Delisted From Nasdaq